1. Home
  2. CGEM vs ASPN Comparison

CGEM vs ASPN Comparison

Compare CGEM & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • ASPN
  • Stock Information
  • Founded
  • CGEM 2016
  • ASPN 2001
  • Country
  • CGEM United States
  • ASPN United States
  • Employees
  • CGEM N/A
  • ASPN N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • ASPN RETAIL: Building Materials
  • Sector
  • CGEM Health Care
  • ASPN Consumer Discretionary
  • Exchange
  • CGEM Nasdaq
  • ASPN Nasdaq
  • Market Cap
  • CGEM 490.3M
  • ASPN 570.6M
  • IPO Year
  • CGEM 2021
  • ASPN 2014
  • Fundamental
  • Price
  • CGEM $7.54
  • ASPN $4.86
  • Analyst Decision
  • CGEM Strong Buy
  • ASPN Strong Buy
  • Analyst Count
  • CGEM 4
  • ASPN 10
  • Target Price
  • CGEM $33.50
  • ASPN $22.44
  • AVG Volume (30 Days)
  • CGEM 457.5K
  • ASPN 1.9M
  • Earning Date
  • CGEM 05-08-2025
  • ASPN 05-08-2025
  • Dividend Yield
  • CGEM N/A
  • ASPN N/A
  • EPS Growth
  • CGEM N/A
  • ASPN N/A
  • EPS
  • CGEM N/A
  • ASPN N/A
  • Revenue
  • CGEM N/A
  • ASPN $436,921,000.00
  • Revenue This Year
  • CGEM N/A
  • ASPN N/A
  • Revenue Next Year
  • CGEM N/A
  • ASPN $35.45
  • P/E Ratio
  • CGEM N/A
  • ASPN N/A
  • Revenue Growth
  • CGEM N/A
  • ASPN 51.90
  • 52 Week Low
  • CGEM $6.85
  • ASPN $4.16
  • 52 Week High
  • CGEM $30.19
  • ASPN $33.15
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 41.51
  • ASPN 32.84
  • Support Level
  • CGEM $7.50
  • ASPN $4.16
  • Resistance Level
  • CGEM $8.97
  • ASPN $5.73
  • Average True Range (ATR)
  • CGEM 0.48
  • ASPN 0.29
  • MACD
  • CGEM -0.04
  • ASPN -0.00
  • Stochastic Oscillator
  • CGEM 2.72
  • ASPN 17.60

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

Share on Social Networks: